231 related articles for article (PubMed ID: 2332729)
1. MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation.
Rosloniec EF; Vitez LJ; Buus S; Freed JH
J Exp Med; 1990 May; 171(5):1419-30. PubMed ID: 2332729
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the antigen binding region of an MHC class II molecule.
Rosloniec EF; Beard KS; Freed JH
Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
[TBL] [Abstract][Full Text] [Related]
3. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
Moreno J; Adorini L; Hämmerling GJ
J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
[TBL] [Abstract][Full Text] [Related]
4. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
5. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
6. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
7. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
8. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking.
Lehmann PV; Cardinaux F; Appella E; Muller S; Falcioni F; Adorini L; Nagy ZA
Eur J Immunol; 1989 Jun; 19(6):1071-7. PubMed ID: 2787751
[TBL] [Abstract][Full Text] [Related]
10. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
Rosloniec EF; Gay D; Freed JH
J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
[TBL] [Abstract][Full Text] [Related]
11. I-A alpha polymorphic residues that determine alloreactive T cell recognition.
Pierres M; Marchetto S; Naquet P; Landais D; Peccoud J; Benoist C; Mathis D
J Exp Med; 1989 May; 169(5):1655-68. PubMed ID: 2469763
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
[TBL] [Abstract][Full Text] [Related]
13. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
MacNeil D; Fraga E; Singh B
Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the allele specific Ag-binding site on murine class II MHC].
Kajino K
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
[TBL] [Abstract][Full Text] [Related]
16. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart.
Donermeyer DL; Beisel KW; Allen PM; Smith SC
J Exp Med; 1995 Nov; 182(5):1291-300. PubMed ID: 7595200
[TBL] [Abstract][Full Text] [Related]
17. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
[TBL] [Abstract][Full Text] [Related]
19. Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma.
Spencer JS; Kubo RT
J Exp Med; 1989 Mar; 169(3):625-40. PubMed ID: 2647893
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution in a cytochrome c T cell stimulatory peptide changes the MHC restriction element from one isotype (I-Ak) to another (I-Ek).
Kelner GS; Jenkins MK; Jemmerson R
Mol Immunol; 1993 Apr; 30(6):569-75. PubMed ID: 7683749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
